{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:21:01Z","timestamp":1788272461547,"version":"build-2803163510"},"reference-count":68,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.bcp.2013.11.015","type":"journal-article","created":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T20:16:00Z","timestamp":1385928960000},"page":"456-466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Alterations in cytochrome P450-derived arachidonic acid metabolism during pressure overload-induced cardiac hypertrophy"],"prefix":"10.1016","volume":"87","author":[{"given":"Ahmed A.","family":"El-Sherbeni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman O.S.","family":"El-Kadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2013.11.015_bib0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","article-title":"Cardiac hypertrophy: the good, the bad, and the ugly","volume":"65","author":"Frey","year":"2003","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.bcp.2013.11.015_bib0010","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0008-6363(97)00278-2","article-title":"Early changes in excitation\u2013contraction coupling: transition from compensated hypertrophy to failure in Dahl salt-sensitive rat myocytes","volume":"37","author":"Nagata","year":"1998","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.bcp.2013.11.015_bib0015","article-title":"Transition from compensated to decompensated cardiac hypertrophy","volume":"4","author":"Sasayama","year":"1999","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.bcp.2013.11.015_bib0020","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1161\/CIR.0b013e31823ac046","article-title":"Heart disease and stroke statistics \u2013 2012 update: a report from the American Heart Association","volume":"125","author":"Roger","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2013.11.015_bib0025","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/jama.292.3.344","article-title":"Trends in heart failure incidence and survival in a community-based population","volume":"292","author":"Roger","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.bcp.2013.11.015_bib0030","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1194\/jlr.R900004-JLR200","article-title":"Thematic review series: proteomics. An integrated omics analysis of eicosanoid biology","volume":"50","author":"Buczynski","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.bcp.2013.11.015_bib0035","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1152\/physrev.00021.2001","article-title":"P-450 metabolites of arachidonic acid in the control of cardiovascular function","volume":"82","author":"Roman","year":"2002","journal-title":"Physiol Rev"},{"key":"10.1016\/j.bcp.2013.11.015_bib0040","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0022-2275(20)32049-6","article-title":"Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase","volume":"41","author":"Capdevila","year":"2000","journal-title":"J Lipid Res"},{"key":"10.1016\/j.bcp.2013.11.015_bib0045","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1152\/physrev.00021.2011","article-title":"Epoxides and soluble epoxide hydrolase in cardiovascular physiology","volume":"92","author":"Imig","year":"2012","journal-title":"Physiol Rev"},{"key":"10.1016\/j.bcp.2013.11.015_bib0050","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1124\/dmd.32.8.840","article-title":"Metabolism of retinoids and arachidonic acid by human and mouse cytochrome P450 1b1","volume":"32","author":"Choudhary","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bcp.2013.11.015_bib0055","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.tcm.2004.04.003","article-title":"Lipoxygenase pathways in atherogenesis","volume":"14","author":"Zhao","year":"2004","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.bcp.2013.11.015_bib0060","doi-asserted-by":"crossref","first-page":"10244","DOI":"10.1016\/S0021-9258(18)86938-1","article-title":"Cytochrome P-450-dependent oxidation of arachidonic acid to 16-, 17-, and 18-hydroxyeicosatetraenoic acids","volume":"265","author":"Falck","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2013.11.015_bib0065","doi-asserted-by":"crossref","first-page":"12912","DOI":"10.1016\/S0021-9258(18)31472-8","article-title":"Formation of 19(S)-, 19(R)-, and 18(R)-hydroxyeicosatetraenoic acids by alcohol-inducible cytochrome P450 2E1","volume":"268","author":"Laethem","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2013.11.015_bib0070","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1124\/jpet.103.059626","article-title":"Catalytic activity and isoform-specific inhibition of rat cytochrome p450 4F enzymes","volume":"308","author":"Xu","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2013.11.015_bib0075","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.2174\/092986710790827843","article-title":"Epoxyeicosatrienoic acid analogs and vascular function","volume":"17","author":"Sudhahar","year":"2010","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bcp.2013.11.015_bib0080","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1046\/j.1440-1681.2000.03349.x","article-title":"Renal and cardiovascular actions of 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids","volume":"27","author":"Roman","year":"2000","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.bcp.2013.11.015_bib0085","first-page":"R228","article-title":"20-HETE is an endogenous inhibitor of the large-conductance Ca(2+)-activated K+ channel in renal arterioles","volume":"270","author":"Zou","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1016\/j.bcp.2013.11.015_bib0090","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000099200","article-title":"20-Hydroxyeicosatetraenoic acid (20-HETE) stimulates migration of vascular smooth muscle cells","volume":"19","author":"Stec","year":"2007","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.bcp.2013.11.015_bib0095","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1124\/jpet.107.130336","article-title":"20-Hydroxyeicosatetraenoic acid stimulates nuclear factor-kappaB activation and the production of inflammatory cytokines in human endothelial cells","volume":"324","author":"Ishizuka","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2013.11.015_bib0100","first-page":"F790","article-title":"20-HETE agonists and antagonists in the renal circulation","volume":"277","author":"Alonso-Galicia","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.bcp.2013.11.015_bib0105","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/01.HYP.0000150782.28485.91","article-title":"Decreased levels of cytochrome P450 2E1-derived eicosanoids sensitize renal arteries to constrictor agonists in spontaneously hypertensive rats","volume":"45","author":"Zhang","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2013.11.015_bib0110","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1161\/01.RES.62.4.687","article-title":"Monohydroxyeicosatetraenoic acids (5-HETE and 15-HETE) induce pulmonary vasoconstriction and edema","volume":"62","author":"Burhop","year":"1988","journal-title":"Circ Res"},{"key":"10.1016\/j.bcp.2013.11.015_bib0115","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/cvr\/cvq016","article-title":"The 5-lipoxygenase\/leukotriene pathway in preclinical models of cardiovascular disease","volume":"86","author":"Poeckel","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.bcp.2013.11.015_bib0120","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0090-6980(87)90264-4","article-title":"12(R)-Hydroxy-5,8,10,14-eicosatetraenoic acid is a chemoattractant for human polymorphonuclear leucocytes in vitro","volume":"34","author":"Cunningham","year":"1987","journal-title":"Prostaglandins"},{"key":"10.1016\/j.bcp.2013.11.015_bib0125","first-page":"H451","article-title":"Effects of 12-HETE on isolated dog renal arcuate arteries","volume":"261","author":"Ma","year":"1991","journal-title":"Am J Physiol"},{"key":"10.1016\/j.bcp.2013.11.015_bib0130","doi-asserted-by":"crossref","first-page":"9920","DOI":"10.1074\/jbc.M111305200","volume":"277","author":"Reddy","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2013.11.015_bib0135","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1084\/jem.20082596","article-title":"Cardiac 12\/15 lipoxygenase-induced inflammation is involved in heart failure","volume":"206","author":"Kayama","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.bcp.2013.11.015_bib0140","doi-asserted-by":"crossref","first-page":"H2138","DOI":"10.1152\/ajpheart.00852.2006","article-title":"Prevention of concentric hypertrophy and diastolic impairment in aortic-banded rats treated with resveratrol","volume":"292","author":"Juric","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.bcp.2013.11.015_bib0145","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/S0024-3205(01)01241-3","article-title":"L-NAME prevents in vivo the inactivation but not the down-regulation of hepatic cytochrome P450 caused by an acute inflammatory reaction","volume":"69","author":"Barakat","year":"2001","journal-title":"Life Sci"},{"key":"10.1016\/j.bcp.2013.11.015_bib0150","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2013.11.015_bib0155","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0022-2275(20)32202-1","article-title":"A method for the determination of 5,6-EET using the lactone as an intermediate in the formation of the diol","volume":"39","author":"Fulton","year":"1998","journal-title":"J Lipid Res"},{"key":"10.1016\/j.bcp.2013.11.015_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/0471140856.tx0423s33","article-title":"Measurement of soluble epoxide hydrolase (sEH) activity","volume":"33","author":"Morisseau","year":"2007","journal-title":"Curr Protocol Toxicol"},{"key":"10.1016\/j.bcp.2013.11.015_bib0165","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0022-3565(24)37530-5","article-title":"Metabolism of arachidonic acid to 20-hydroxy-5,8,11,14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11","volume":"285","author":"Powell","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2013.11.015_bib0170","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1042\/BJ20050681","article-title":"Cytochrome P450\/NADPH-dependent biosynthesis of 5,6-trans-epoxyeicosatrienoic acid from 5,6-trans-arachidonic acid","volume":"390","author":"Roy","year":"2005","journal-title":"Biochem J"},{"key":"10.1016\/j.bcp.2013.11.015_bib0175","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jpba.2007.11.047","article-title":"Development and validation of a high-performance liquid chromatography\u2013electrospray mass spectrometry method for the simultaneous determination of 23 eicosanoids","volume":"46","author":"Blewett","year":"2008","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.bcp.2013.11.015_bib0180","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1124\/dmd.104.002253","article-title":"tert-Butylhydroquinone is a novel aryl hydrocarbon receptor ligand","volume":"33","author":"Gharavi","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bcp.2013.11.015_bib0185","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0014-5793(96)01017-4","article-title":"Lipoxygenase activity in heart cells","volume":"395","author":"Breitbart","year":"1996","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bcp.2013.11.015_bib0190","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1046\/j.1365-2125.1999.00030.x","article-title":"Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of rosiglitazone","volume":"48","author":"Baldwin","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bcp.2013.11.015_bib0195","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0090-9556(25)06745-5","article-title":"Human liver lauric acid hydroxylase activities","volume":"23","author":"Castle","year":"1995","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bcp.2013.11.015_bib0200","doi-asserted-by":"crossref","first-page":"31280","DOI":"10.1074\/jbc.M109.025627","article-title":"Identification of 13-hydroxy-14,15-epoxyeicosatrienoic acid as an acid-stable endothelium-derived hyperpolarizing factor in rabbit arteries","volume":"284","author":"Chawengsub","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2013.11.015_bib0205","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1124\/dmd.108.023077","article-title":"Modulation of cytochrome P450 gene expression and arachidonic acid metabolism during isoproterenol-induced cardiac hypertrophy in rats","volume":"36","author":"Zordoky","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bcp.2013.11.015_bib0210","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.taap.2009.09.012","article-title":"Acute doxorubicin cardiotoxicity alters cardiac cytochrome P450 expression and arachidonic acid metabolism in rats","volume":"242","author":"Zordoky","year":"2010","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.bcp.2013.11.015_bib0215","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/j.1476-5381.2009.00461.x","article-title":"3-Methylcholanthrene and benzo(a)pyrene modulate cardiac cytochrome P450 gene expression and arachidonic acid metabolism in male Sprague Dawley rats","volume":"158","author":"Aboutabl","year":"2009","journal-title":"Br J Pharmacol"},{"issue":"12","key":"10.1016\/j.bcp.2013.11.015_bib0220","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.3109\/00498254.2012.693971","article-title":"Acute arsenic toxicity alters cytochrome P450 and soluble epoxide hydrolase and their associated arachidonic acid metabolism in C57Bl\/6 mouse heart","volume":"42","author":"Anwar-Mohamed","year":"2012","journal-title":"Xenobiotica"},{"key":"10.1016\/j.bcp.2013.11.015_bib0225","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/CIRCHEARTFAILURE.108.839761","article-title":"Small animal models of heart failure: development of novel therapies, past and present","volume":"2","author":"Patten","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.bcp.2013.11.015_bib0230","doi-asserted-by":"crossref","first-page":"F288","DOI":"10.1152\/ajprenal.00171.2006","article-title":"Epoxyeicosatrienoic acids affect electrolyte transport in renal tubular epithelial cells: dependence on cyclooxygenase and cell polarity","volume":"293","author":"Nusing","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.bcp.2013.11.015_bib0235","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1517\/17425250902932923","article-title":"Epoxyeicosatrienoic acids: formation, metabolism and potential role in tissue physiology and pathophysiology","volume":"5","author":"Kaspera","year":"2009","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.bcp.2013.11.015_bib0240","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/01.RES.0000155332.17783.26","article-title":"Epoxyeicosatrienoic acids are released to mediate shear stress-dependent hyperpolarization of arteriolar smooth muscle","volume":"96","author":"Huang","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.bcp.2013.11.015_bib0245","doi-asserted-by":"crossref","first-page":"R1239","DOI":"10.1152\/ajpregu.00185.2007","article-title":"Contribution of epoxyeicosatrienoic acids to flow-induced dilation in arteries of male ERalpha knockout mice: role of aromatase","volume":"293","author":"Sun","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.bcp.2013.11.015_bib0250","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.atherosclerosis.2012.03.022","article-title":"Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease","volume":"222","author":"Theken","year":"2012","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.bcp.2013.11.015_bib0255","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/FJC.0b013e31827fe59c","article-title":"Soluble epoxide hydrolase inhibition does not prevent cardiac remodeling and dysfunction following aortic constriction in rats and mice","volume":"61","author":"Morgan","year":"2012","journal-title":"J Cardiovasc Pharmacol"},{"issue":"8","key":"10.1016\/j.bcp.2013.11.015_bib0260","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1111\/bph.12066","article-title":"Soluble epoxide hydrolase inhibitor, tups, protects against isoproterenol-induced cardiac hypertrophy","volume":"168","author":"Althurwi","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2013.11.015_bib0265","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1124\/dmd.112.046631","article-title":"Chronic doxorubicin cardiotoxicity modulates cardiac cytochrome P450-mediated arachidonic acid metabolism in rats","volume":"40","author":"Alsaad","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bcp.2013.11.015_bib0270","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1161\/01.RES.88.1.70","article-title":"Overexpression of 12-lipoxygenase causes cardiac fibroblast cell growth","volume":"88","author":"Wen","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.bcp.2013.11.015_bib0275","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1050-1738(03)00027-6","article-title":"Overexpression of 12-lipoxygenase and cardiac fibroblast hypertrophy","volume":"13","author":"Wen","year":"2003","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.bcp.2013.11.015_bib0280","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/cvr\/cvn346","article-title":"Eicosanoid signalling pathways in the heart","volume":"82","author":"Jenkins","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.bcp.2013.11.015_bib0285","doi-asserted-by":"crossref","first-page":"29109","DOI":"10.1074\/jbc.M802143200","article-title":"Inflammatory pathways are activated during cardiomyocyte hypertrophy and attenuated by peroxisome proliferator-activated receptors PPARalpha and PPARdelta","volume":"283","author":"Smeets","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2013.11.015_bib0290","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/eurheartj\/ehm008","article-title":"Hypertrophy and inflammation: too much for one heart","volume":"28","author":"Bayes-Genis","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.bcp.2013.11.015_bib0295","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/eurheartj\/ehl525","article-title":"Myocarditis in hypertrophic cardiomyopathy patients presenting acute clinical deterioration","volume":"28","author":"Frustaci","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.bcp.2013.11.015_bib0300","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/jhh.2011.113","article-title":"Inflammatory markers are associated with left ventricular hypertrophy and diastolic dysfunction in a population-based sample of elderly men and women","volume":"27","author":"Masiha","year":"2013","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.bcp.2013.11.015_bib0305","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1476-9255-7-21","article-title":"Captopril reduces cardiac inflammatory markers in spontaneously hypertensive rats by inactivation of NF-\u03baB","volume":"7","author":"Miguel-Carrasco","year":"2010","journal-title":"J Inflamm (Lond)"},{"key":"10.1016\/j.bcp.2013.11.015_bib0310","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.freeradbiomed.2005.08.002","article-title":"Attenuation of cardiac hypertrophy by inhibiting both mTOR and NFkappaB activation in vivo","volume":"39","author":"Ha","year":"2005","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.bcp.2013.11.015_bib0315","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/01.CIR.97.14.1382","article-title":"Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats","volume":"97","author":"Bozkurt","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2013.11.015_bib0320","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0008-6363(98)00305-8","article-title":"Cardiac fibrosis and inflammation: interaction with hemodynamic and hormonal factors","volume":"41","author":"Nicoletti","year":"1999","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.bcp.2013.11.015_bib0325","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.CIR.91.1.161","article-title":"Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensive rat","volume":"91","author":"Conrad","year":"1995","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.bcp.2013.11.015_bib0330","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1208\/s12248-012-9425-7","article-title":"Determination of the dominant arachidonic acid cytochrome P450 monooxygenases in rat heart, lung, kidney and liver: protein expression and metabolite kinetics","volume":"15","author":"El-Sherbeni","year":"2012","journal-title":"AAPS J"},{"key":"10.1016\/j.bcp.2013.11.015_bib0335","doi-asserted-by":"crossref","first-page":"12551","DOI":"10.1074\/jbc.272.19.12551","article-title":"Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes","volume":"272","author":"Wu","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2013.11.015_bib0340","first-page":"R1691","article-title":"Kinetic profile of the rat CYP4A isoforms: arachidonic acid metabolism and isoform-specific inhibitors","volume":"276","author":"Nguyen","year":"1999","journal-title":"Am J Physiol"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295213007466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295213007466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:53:53Z","timestamp":1746060833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295213007466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0006295213007466"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2013.11.015","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alterations in cytochrome P450-derived arachidonic acid metabolism during pressure overload-induced cardiac hypertrophy","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2013.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}